Fuse Biotherapeutics Competitors and Similar CompaniesClear all

Fuse Biotherapeutics's competitors and similar companies include UT Health San Antonio MD Anderson Cancer Center, Cyteir Therapeutics and Lion TCR.
Fuse Biotherapeutics
Fuse Biotherapeutics
Fuse Biotherapeutics is a developer of immunotherapies for cancer patients.
UT Health San Antonio MD Anderson Cancer Center
UT Health San Antonio MD Anderson Cancer Center
UT Health San Antonio MD Anderson Cancer Center is an institution that researches cancer and provides patients care.
Cyteir Therapeutics
Cyteir Therapeutics
Cyteir Therapeutics is a company that develops medicines for the treatment of cancer.
Lion TCR
Lion TCR
Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.
Founding Date
Founding Date
2021
Founding Date
N/A
Founding Date
2012
Founding Date
N/A
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Private
Tags
Locations
Locations
Woburn, US HQ
Locations
San Antonio, US HQ
Locations
Lexington, US HQ
Locations
Singapore, SG HQ
Guangzhou, CN
Singapore, SG
Singapore, SG
Employees
Employees
5
Employees
N/A
Employees
4615% increase
Employees
N/A

Funding

Latest funding round
Latest funding round
$ 9.5m (about 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 20m (over 6 years ago)
Total funding raised
Total funding raised
$ 9.5m
Total funding raised
N/A
Total funding raised
$ 76.7m
Total funding raised
$ 20m
For sources of this data, please see the company profile

View Company Profiles

UT Health San Antonio MD Anderson Cancer Center
HQ
San Antonio, US

UT Health San Antonio MD Anderson Cancer Center is an institution that researches cancer and provides patients care.

View company
Cyteir Therapeutics
HQ
Lexington, US
Employees
46↑ 15% increase

Cyteir Therapeutics is a company that develops medicines for the treatment of cancer.

View company
Lion TCR
HQ
Singapore, SG

Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.

View company